Welcome to article directory Cerebral Palsy News. Here You can find interesting and useful information on most popular themes.

There are 799 published articles and 408 registered authors in our article directory.

Recent Articles

Actos Bladder Cancer Top News

Actos Bladder Cancer : In both cases, the first step is a cystoscopy and removal of the tumor. For smaller superficial tumors, removal can sometimes be accomplished with biopsy forceps alone. For larger tumors, a resectoscope is used. In the case of a large invasive cancer which clearly is growing deep into the bladder, the urologist may choose not to remove the entire tumor since further surgery will be required and there is little to be gained by resecting more (and possibly more to be lost with a greater chance of serious bleeding or a bladder perforation with a more extensive resection). If however, the individual will not be a candidate for open surgery (due to advanced age or other medical risk factors), a more thorough resection may be advisable to prevent recurrence of future hematuria, or perhaps to allow for an alternate form of therapy such as a “bladder sparing” regimen, consisting of transurethral .resection, radiation, and chemotherapy.

In a small percentage of individuals a partial cystectomy, removing just part of the bladder, is possible, and may be the preferred form of open surgery. This procedure can generally be accomplished if the cancer is located in an accessible area of the bladder such as the dome, is not multi-focal, or too large. Many tumors arc too large, are multi-focal, or are in an inaccessible area, and therefore are not treatable with partial cystectomy. Furthermore, even when an individual presents with a cancer which is treatable via partial cystectomy, removal of the entire bladder may be preferable since recurrent, invasive disease in the remaining bladder is probable. For the elderly or those in poor health, and others with a limited life expectancy, partial cystectomy may be ideal if doable.

Radical cystectomy is a major surgery with potential complications. You therefore, need to be in the best possible medical condition prior to surgery. Your health care history will be reviewed by your urologist. If you have specific medical conditions such as heart disease or respiratory disease, a referral to the specialist or primary care physician overseeing management of these conditions is usually warranted to make sure your risk factors have been corrected or improved, to allow for safe surgery. If you have a medical condition which places you at substantial risk of a major complication, it should be addressed prior to proceeding with a surgery of this extent. For example, if you have a heart condition, such as an irregular heart beat, medication may need to be adjusted. Some patients may need to go on lung medication to improve their lung function. On occasion, an individual may need to even have surgery for a blocked heart vessel prior to going ahead with a radical cystectomy. If you still are smoking, you should definitely stop at least two weeks prior to surgery.

More information on Actos Bladder Cancer

You will need to discontinue any medications that can affect your ability to clot during surgery. These may include coumadin and aspirin and other medications which keep your blood from readily clotting. Some vitamins such as Vitamin E can also affect clotting and should be stopped. Herbal remedies will also need to be reviewed with your urologist, as some may affect your ability to clot. Your urologist will go over the medications and let you know which will need to be discontinued prior to surgery. If you drink more than the equivalent of 2 ounces of alcohol per day, it is important to stop drinking alcohol preferably at least a week or more prior to surgery. If you are an alcoholic and drink large quantities of alcohol on a regular basis, you will face the possibility of delirium tremens (DTs) after surgery when you cannot drink alcohol. DTs is a serious medical complication with a high mortality rate. If you have any doubts regarding your consumption of alcohol, you should discuss this with your urologist.

You may wish to donate blood which will be held in the blood bank for you exclusively during or after surgery. These units of blood are called autologous units and may be transfused only into you. Your urologist will advise you if it is necessary for you to donate blood. If you do choose to donate blood, generally a unit can be given every 7-10 days. It is advisable to take iron supplements during donation so your body can quickly rebuild its blood supply prior to surgery.

If you have experienced a recent illness which has weakened you, it is important to be fully recovered prior to proceeding with the operation. Illness may result in a state of malnutrition. If you have experienced recent weight loss, it may be important to take protein supplements to build up your body prior to surgery.

Information from other sources on Actos Bladder Cancer

Because your urologist will be using a piece of your bowel to create a new urinary drainage system, your small and large bowel will need to be thoroughly cleaned out prior to surgery. Your urologist will prescribe cleansing agents such as Golytely or Fleet Phospho-soda the day before surgery to rid the bowel of fecal contents. It is also standard to take a number of antibiotic pills the day before surgery to reduce the bacterial count in the bowel. You will be on “clear liquids” the day before with nothing to eat or drink after midnight. Your urologist will give you detailed instructions regarding the bowel prep and a prescription for the antibiotics.

Getting a good night’s sleep the evening before surgery will help you deal with the initial anxiety as you travel to the hospital. Ask your physician for a “sleeping pill” if you know you will be facing a sleepless night.

If you are very anxious about your upcoming surgery, talk to your urologist or primary care physician. A prescription for medication to reduce anxiety may be appropriate. For those individuals who wish to “go natural,” various techniques such as meditation, guided imagery, or Reiki can be practiced prior to and after surgery to reduce stress and anxiety and enhance your recovery. These modalities are generally available in most communities. If you need help in learning these techniques, ask your physician for a referral or call your hospital for resources in your community.

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

http://www.seedol.com

Posted in Cerebral Palsy News | Tagged , |

Multaq Proclamation

Multaq : Imaging Studies

Usually the doctor will want to obtain at least one imaging study (usually a sono­gram) at some point during the diagnostic evaluation of chronic hepatitis B, especially when LFTs are elevated. While an enlarged liver or spleen may be detected on occasion, in general, imaging studies are usually normal—even in advanced stages of the disease. If liver cancer (hepatoma) is present, a mass may be revealed. See chapter 19 for more information on liver tumors. However, just because the liver looks normal on an imaging study does not mean that the liver is normal. That is why a liver biopsy is necessary when more information about the condition of the liver is needed.

More information on Multaq

The Different Types of Chronic Hepatitis B

People with chronic hepatitis B may be divided into three categories: (1) inactive hepatitis B surface antigen (HBsAg) carrier state; (2) chronic hepatitis B, which is divided into HbeAg positive and HBeAg negative chronic hepatitis B; and (3) re­solved chronic hepatitis B. Everyone with chronic hepatitis B is, by definition, both HBsAg and HBcAb positive. (Refer to table 9.1 on page 100 for a discus­sion of these and some related terms.) This means that both the hepatitis B sur­face antigen and core antibody are detectable in their blood.

Inactive HBsAg Corner Stote

The first type of chronic hepatitis B is found in a person who carries hepatitis B, is HBsAg and HBcAb positive, but who has normal liver enzymes (AST and ALT), a normal physical exam, and is asymptomatic. Such a person is referred to as an in­active carrier of hepatitis B. HBeAg and HBV DNA are negative, and HBeAb is typically positive—indicating that this person is not infectious to others. Inactive carriers of HBV usually have minimal, if any, liver inflammation or damage. They usually live a normal life without any complications due to their liver disease. However, compared with the genera! population, these people are at a somewhat higher risk for cirrhosis and liver cancer. Therefore, regular observation—in the form of visits to the doctor approximately one to two times per year for a physical exam and blood tests—is necessary to check for early signs of disease progression.

 

Information from other sources on Multaq

Liver Biopsy

As with all liver diseases, even if a person feels Fine, that’s no guarantee that her liver is fine. The only way to determine the degree to which one’s liver is injured is by examining a sample of the liver under a microscope. Therefore, in addition to ob­taining a battery of blood tests, including LFTs and the hepatitis B serology, the doctor will need to perform a liver biopsy to determine the full extent of damage done to the liver by the virus and to determine if treatment is necessary. A liver

 

biopsy is the only reliable means of determining the presence or absence of cir­rhosis. Some studies have demonstrated that the results of a liver biopsy per­formed promptly after diagnosis can predict the future course of disease.

Our use of the term or terms Multaq is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Multaq visit our site often.

http://www.seedol.com

Posted in Cerebral Palsy News | Tagged , |

Multaq and Liver Damage Information

Multaq and Liver Damage : In addition, these people are at risk for reactivation of the virus—return of HBeAg positivity. This occurs approximately 20 to 30 percent of the time. An in­dividual’s likelihood of reactivation increases if their immune system becomes suppressed. Such an occurrence may happen during treatment with immunosup­pressive drugs, such as steroids (prednisone, for example), or during a severe ill­ness, such as AIDS or cancer. Inactive carriers can also have flares of hepatitis. This may occur with or without the return of HBeAg and is noted by elevations in liver enzymes to approximately five to ten times the upper limit of normal. Repeated flares may lead to disease progression, liver scarring, and even liver failure.

More information on Multaq and Liver Damage

Acute flares of hepatitis B should be distinguished from additional infection with hepatitis A, C, or D. Infection with an additional hepatitis virus is known as superinfection. It has been estimated that approximately 20 to 30 percent of such flares are due to superinfection with another hepatitis virus. Superinfection is as­sociated with an increased risk of liver failure.

Information from other sources on Multaq and Liver Damage

Chronic Hepatitis B

The second type of chronic hepatitis B is termed chronic hepatitis B and is found in a person who, in addition to carrying the HBsAg, also carries HBV DNA. The presence of detectable levels of HBV DNA indicates that a person is highly con­tagious or infectious to others. People with chronic hepatitis B may be either pos­itive or negative for HBeAg. In both HBeAg positive and HBeAg negative people, liver enzymes are either persistently or intermittently elevated, and liver biopsy results typically reveal inflammation and damage. People with chronic hepatitis are likely to have a progressive disease leading to cirrhosis.

Our use of the term or terms Multaq and Liver Damage is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Multaq and Liver Damage visit our site often.

http://www.seedol.com

Posted in Cerebral Palsy News | Tagged , |

Multaq Attorney Legal News

Multaq Attorney : Chronic Hepatitis B—HBeAg positive

People with HBeAg positive chronic hepatitis B have only an 8 to 15 percent probability each year of becoming negative for HBeAg and HBV DNA. This is known as a spontaneous remission. When this happens, temporary gross eleva­tion in transaminases (AST and ALT) is observed, followed by a rapid return to normal levels. Antibodies to HBeAg (known as HBeAb) are formed. This is known as seroconversion. These people are no longer contagious to others and they experience minimal, if any. liver damage going forward. In fact, any past liver damage often resolves within the next few years. This resolution confirms the transition from chronic hepatitis B into the inactive HBsAg carrier state, as discussed above. Women, older people, and those individuals with genotype B are likeliest to seroconvert. Unfortunately, reactivation to the infectious state can occur in some of these people. Thus, these people must be observed carefully, ft is not clear which factors play a role in causing some people to relapse into an in­fectious state. Certainly excessive alcohol intake may have a harmful effect on people with chronic hepatitis B. And it has been demonstrated that excessive iron intake may promote persistent HBV replication in some people. (Excessive iron in itself can damage the liver and may lead to cirrhosis and liver cancer. This is dis­cussed in more detail in chapters 18 and 23.) Therefore, people with chronic hep­atitis B are advised to refrain from alcohol intake and should avoid excess iron supplementation. Seroconverters whose immune systems subsequently become compromised are at risk for a relapse. Immune-system function can become im­paired by a number of factors, including infection with the human immunodefi­ciency virus (HIV), treatment with chemotherapeutic agents for cancer, or use of corticosteroids such as prednisone.

More information on Multaq Attorney

Chronic Hepatitis B—HBeAg negative

People with chronic hepatitis B who are negative for HBeAg have a mutant strain of chronic hepatitis B. A mutation is a permanent alteration of the hepatitis B virus’s genetic makeup. There are many different types of hepatitis B mutations. In this case, the genetic mutation is characterized by the failure of the virus to make the hepatitis B “e” antigen (HBeAg). This is known as a precore mutation. This mutation does not affect the virus’s ability to replicate. Therefore, on blood tests, these people are negative for HBeAg, but positive for HBV DNA. Men are more likely than women to have this mutation, and HBeAg negative chronic hep­atitis B does not occur with genotype A. Precore mutant hepatitis B has been responsible for several cases of surprised transmission of hepatitis B to others, as these people were unaware that they were infectious. This strain of hepatitis B may be genetically superior to HBeAg positive chronic hepatitis B. Thus, liver disease is usually more active and liver scarring more advanced. These individu­als are more likely to develop cirrhosis compared with HBeAg positive people. Furthermore, this strain is usually more resistant to treatment.

Information from other sources on Multaq Attorney

In some instances, a person who is HBsAg positive can become HBsAg negative, which is the last category of chronic hepatitis B, known as resolved chronic hep­atitis B. However, it is very uncommon and occurs only at a rate of approxi­mately 0.5 to 2 percent of hepatitis patients each year. Loss of HBsAg is more likely to occur in women than men and is rare in people with the mutant strain.

Most, but not all, people who do resolve will develop the hepatitis B anti­body (HbsAb). Liver enzymes (ALT and AST) normalize. Clearance of hepatitis B antigen decreases the risk of progression to liver failure and liver cancer. Most people who have resolved have a benign course of disease. However, approxi­mately half of these people continue to have very low levels of HBV DNA and are considered to be noninfectious to others.

Our use of the term or terms Multaq Attorney is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Multaq Attorney visit our site often.

http://www.seedol.com

Posted in Cerebral Palsy News | Tagged , |

Multaq Attorneys Scoop

Multaq Attorneys : A low level, also considered a noninfectious level of HBV DNA, is defined as less than 10,000 copies/ml. These low HBV DNA levels are only detectable if a very sensitive laboratory assay known as the polymerase chain reaction (PCR) is used. The PCR assay has the ability to detect levels as low 200 copies/ml. (These test results are often reported in picograms per milliliters (pg/ml) lpg/ml =

280,0 copies/ml.) In situations where people with resolved hepatitis B experi­ence severe immune suppression, such as cancer chemotherapy or organ trans­plantation, chronic hepatitis B can be reactivated. This means that HBsAg will become positive again.

More information on Multaq Attorneys

More than 1 million people worldwide die each year from hepatitis B. So, why is it that some people can live a long healthy life with hepatitis B and others experience serious complications? Well, it has been demonstrated that there are many factors that influence the progression from a mild, innocuous illness to a grave outcome. These factors include advanced age, general poor health—tor ex­ample, depressed immune status such as additionally infection with HIV; the presence of advanced damage found on a liver biopsy sample; and the presence of markers of chronicity and active infectiousness, especially HBV DNA. Simi­larly, people who do not clear HBeAg (spontaneous remission) tend to have a more aggressive course than those who clear HBeAg. In fact, in some studies it has been shown that people who clear HBeAg rarely progress to cirrhosis. Fur­thermore, people who clear HBeAg. whether spontaneously or from treatment, have a decreased incidence of liver failure and an improved long-term survival rate. People who are additionally infected with the hepatitis delta virus (HDV) (see page 106) or the hepatitis C virus (see chapter 10) also have poorer prog­noses. In addition, it has been shown that the outcome of a person infected with HBV is highly dependent upon the stage at which she first obtained medical at­tention. Those people who have more advanced disease on liver biopsy samples when initially seen by a specialist have a shorter survival time. It has also been found that people with genotype C have a worse prognosis than those with other genotypes. Lastly, it has been demonstrated that people infected with HBV are more susceptible to the toxic effects of alcohol on the liver than are those with­out HBV. Therefore, it is important for people with chronic hepatitis B to avoid all intake of alcohol, as alcohol may worsen the course and accelerate the pro­gression of the disease. See chapter 17 for more information on

Information from other sources on Multaq Attorneys

The Long-term Prognosis for Those with Chronic Hepatitis B

The probability each year that a person with chronic hepatitis B will develop cir­rhosis is about 2 percent. However, different studies have reported rates varying from 0.1 to 10 percent per year. The cumulative probability of progression to cir­rhosis over five years is approximately 15 to 20 percent. After the development of cirrhosis, the probability of developing serious complications, such as decom­pensated cirrhosis, is about 2 to 10 percent each year. The five-year survival rate after cirrhosis has developed varies from 52 to 80 percent. However, if a person has decompensated cirrhosis, the five-year survival rate decreases to between 14 and 35 percent.

Our use of the term or terms Multaq Attorneys is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Multaq Attorneys visit our site often.

http://www.seedol.com

Posted in Cerebral Palsy News | Tagged , |

Multaq Lawsuit Breaking News

Multaq Lawsuit : Chronic Hepatitis B and Long-term Liver Cancer Risk

People with chronic hepatitis B are at increased risk for developing liver cancer. The exact risk is unknown, but in some studies, people with chronic hepatitis B were two hundred times more likely to develop liver cancer compared with people without this disease. Cancer usually occurs in those who have developed cirrhosis. However, cancer can also occur in chronic HBV carriers without cir­rhosis. In fact, in some parts of the world where hepatitis B is endemic, such as in Africa, up to 30 percent of people with chronic hepatitis B develop liver can­cer without underlying cirrhosis.

Prom the time a person becomes infected with HBV, liver cancer generally takes about twenty to thirty years to develop. Thus, people who were infected at birth can develop liver cancer as early as the age of twenty. It appears that infec­tion with both HBV and HCV or infection with both HBV and HDV, drinking ex­cessive alcohol, and having a family history of HCC can increase the likelihood that a person will develop liver cancer. It has been noted that men appear to have an increased risk ot developing HCC compared to women. Whether this is due to hormonal differences is unclear. See chapter 19 for more information on HBV and liver cancer.

More information on Multaq Lawsuit

THE HEPATITIS DELTA VIRUS (HDV)

Hepatitis D is inflammation of the liver due to a virus called the hepatitis delta virus (HDV). HDV is a virus that can live only in people with hepatitis B. Ap­proximately 70,000 people in the United States are infected with HDV. Although HDV only accounts for a small percentage of cases of chronic viral hepatitis, it tends to be particularly severe and to have significant long-term consequences. In fact, chronic hepatitis D causes more than one thousand deaths each year in the United States. In the 1970s, hepatitis delta virus infection was endemic through­out Southern Europe. However, by the 1990s the incidence of HDV infection had significantly decreased. In fact, one study done in Italy estimated that the num­ber of cases of HDV within that country decreased by 1.5 percent each year from 1987 to 1997. And, it is anticipated that this trend will continue. Currently, new HDV infections are rare.

Information from other sources on Multaq Lawsuit

HDV infection may be silent or may cause the same kind of fatigue and other symptoms associated with other forms of hepatitis. However, up to 20 percent of hepatitis D patients develop fulminant hepatitis, a particularly serious condition that requires hospitalization. See chapter 7 for a discussion on fulminant hepatitis.

HDV is transmitted through the same blood, sexual, and perinatal routes as HBV, which were discussed on page 92. There are two ways in which a person infected with HBV may become infected with HDV: coinfection and superinfection. When HBV and HDV are acquired at the same time, it is known as coinfection. In 90 to 95 percent of cases, such people will be able to completely eliminate both viruses from their bodies. This means that only approximately 5 to 10 percent of coinfected individuals go on to develop chronic hepatitis B and D. HDV can also be acquired by someone who already has chronic hepatitis B. This is known as superinfection. In contrast to people infected with both viruses simultaneously, approximately 70 to 95 percent of people who become infected in this two-step fashion progress to chronic hepatitis D.

Our use of the term or terms Multaq Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Multaq Lawsuit visit our site often.

http://www.seedol.com

Posted in Cerebral Palsy News | Tagged , |

Multaq Lawyer Message

Multaq Lawyer :

LONG-TERM PROGNOSIS FOR THOSE WITH CHRONIC HEPATITIS B AND D

Compared with people who have chronic hepatitis B alone, those with chronic infections of both HBV and HDV are more likely to have a poor outcome. These people tend to develop cirrhosis more frequently and more rapidly than those with chronic hepatitis B alone. Approximately 60 to 70 percent ot all people with chronic hepatitis D develop cirrhosis, and 15 percent of them develop cirrhosis in two years or less from the time of initial infection. This is much more frequent and rapid than for any other form of chronic viral hepatitis. People with both chronic hepatitis B and chronic hepatitis D are also more likely to develop com­plications, such as liver failure and liver cancer, and are more likely to require a liver transplant as compared with people suffering from other forms of chronic viral hepatitis.

More information on Multaq Lawyer

WHAT IS HEPATITIS C?

Hepatitis C is inflammation of the liver due to a virus called the hepatitis C virus (HCV). After the discovery of the hepatitis A virus in 1973 and the hepatitis B virus in 1963, the remaining hepatitis viruses were lumped into the category of non-A non-B (NANB) hepatitis. Any cases of acute or chronic hepatitis or cirrhosis with­out identifiable causes were suspected to be a result of the NANB hepatitis viruses. In 1989, a major breakthrough regarding this mysterious and intriguing disease occurred—the hepatitis C virus was identified. Now, HCV is believed to be the virus responsible for more than 90 percent of all cases of NANB hepatitis.

Information from other sources on Multaq Lawyer

HCV is the most common cause of cirrhosis and liver cancer in the United States. More than 4 million Americans (approximately 2 percent of the United States population) and more than 170 million people worldwide (ap­proximately 3 percent of the world’s population) are infected with HCV. (HCV is more prevalent in Africa, the eastern Mediterranean, Southeast Asia, and the western Pacific than in the United States.) The Centers for Disease Control (CDC) estimates that only a small percentage (probably around 5 percent) of in­fected individuals are even aware that they harbor this virus in their bodies.

People between the ages of forty and fifty-nine are most likely to be diag­nosed with HCV. And it is estimated that there will be a fourfold increase in the number of adults diagnosed with HCV by the year 2015. While HCV can infect anyone with risk factors, it has been found to be more common among certain subgroups of people. For example, the prevalence of HCV among prison inmates is between 39 and 54 percent, among intravenous drug users between 70 and 90 percent, and among those attending Veterans Administration outpatient clinics between 18 and 40 percent.

Our use of the term or terms Multaq Lawyer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Multaq Lawyer visit our site often.

http://www.seedol.com

Posted in Cerebral Palsy News | Tagged , |

Actos Bladder Cancer Top News

Actos Bladder Cancer : You probably have already figured out that cystectomy is a surgical procedure performed under anesthesia in a hospital setting. Depending on what kind of bladder reconstruction you have, you may stay in the hospital anywhere from 5 to 14 days. The descriptions included here of medical procedures and treat­ments are of a general nature; your own experience may differ from what is discussed here. With cystectomy, an incision is made through the abdominal wall, so you can expect some mild discomfort at the incision site. The inci­sion will be covered, and you probably won’t be able to shower or get the incision wet for about a week to 10 days. You may have a drain from the incision, a flexible tube with a hollow bulb on the end that you will remove, empty, flush out, and reattach as needed. Your doc­tor will remove the drain (it’s painless) and any stitches or staples in a follow-up visit 10 days or so after your surgery.

Some possible complications include infection, bleeding, blood clots, or intestinal obstruction. You may experience some difficulties with your urinary diversion system. You’ll be asked to wait for a few weeks after surgery before you drive, and your doctors are likely to want you to refrain for several weeks from doing anything that strains the abdominal area, such as pushing and pulling a vacuum cleaner or lifting heavy objects or engaging in any other activity that might damage the scar or even pull the scar tissue apart, thereby risking the formation of a hernia. A her­nia occurs when your surgical scar pulls apart under the skin and allows a part of the underlying bowel to poke forward, creating a noticeable lump. It can interfere with the functioning of your bowel and therefore needs to be fixed, either with an external truss or sup­port, or possibly through another surgical operation.

It’s smarter just to avoid the risk in the first place by not stressing the scar soon after surgery. This is the time to take it easy and when possible allow friends or family to pamper you by helping with chores and housework. Just don’t get too used to having someone bring you the morning newspaper and a cup of coffeel Generally it’s a good idea to talk about this with your doctor and find out what you can and cannot safely do.There are some negative consequences of cystectomy that you should discuss thoroughly with your medical team. As mentioned above, there may be changes in urinary function. These will depend largely on the type of surgery and on whether an artificial bladder has been created. Sometimes while the abdominal tissues are healing after surgery there will be a period of irregular bowel function, during which you will unexpectedly have to deal with diarrhea or constipation.

More information on Actos Bladder Cancer

Occasionally there will be some swelling in one or both legs, due either to fluid retention or the formation of scar tissue around the lymph vessels that drain the legs. Often there will be the presence of an asymptomatic, low-grade chronic urinary tract infection that will be identified upon routine testing. This occurs because of the changed pattern of emptying the new bladder. Usually it causes no problems and doesn’t require active treatment with antibiotics. Other issues also arise. Worries about possible changes in sexual function are common, and very normal. Sexual function often does change after cystectomy That doesn’t mean you can’t have an active, playful, pleasurable sex life with your partner. It does mean that you’ll probably explore innovative strategies as you seek comfortable ways to experience fulfillment.

Men experience more extreme changes in sexual function after surgeiy than women do. Around half the men who undergo cystec­tomy experience nerve damage that leaves them impotent afterwards, a serious lifestyle change that is not only physical but emotional, requiring much thoughtful discussion between you, your partner, and your medical team both before surgery and after. If you are able to have an erection after surgery, you won’t be able to ejaculate, because ’without a prostate, your body is no longer able to produce semen. You’ll find that the physical sensation of orgasm is different from what you are accustomed to. It’s not unpleasant; just different. In general, the younger you are at the time of surgery, the more likely you will be to have erections or to regain over time the capability of having them. There are surgical procedures, such as penile inserts, that can help make sexual activity possible.

For women, a cystectomy includes the removal of the uterus and part of the vaginal wall. What does that mean for you? Well, for one thing, your vagina may be narrower as a result of the surgery. Usually it’s possible to continue to have intercourse, although sometimes there can be some pain involved. Be sure to talk to your doctor if you do experience pain as there are methods of reducing this.

Information from other sources on Actos Bladder Cancer

Most women diagnosed with bladder cancer already have experienced menopause. (Typically, women who receive diagnoses of bladder cancer are older.) For younger women, that may not be the case. The removal of the uterus and pos­sibly of other female organs near the Most women diagnosed bladder brings an abrupt end to the child- with bladder cancer bearing years. It may also set off typical already have experienced menopausal symptoms such as hot flash- menopause. (Typically, es or mood swings if the ovaries have women who receive been removed at surgery (removal of diagnoses of bladder ovaries is unusual). If you find yourself cancer are older.) feeling depressed or blue or uncomfort­able from hot flashes, talk to your doctor. You don’t have to feel that way; there are options available for you to consider.

As is recommended for men, talking with your partner and your medical team about the physical and emotional changes that you may experience after a cystectomy is an important part of the process, one that deserves as much consideration as the more immediate decisions about which treatment options you want to pursue. Keep in mind that cystectomy is a life-preserving weapon against invasive cancer. That doesn’t mean you can’t or shouldn’t consider the possibility of impotence or altered sexual function with your partner, or the inability to carry a child. It does offer the hope that you can celebrate many more years of healthy, loving life with your friends and family. That’s an important thing to remember at a time when life may seem to be serving you big helpings of despair.

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

http://www.seedol.com

Posted in Cerebral Palsy News | Tagged , |

Actos Side Effects Info

Actos Side Effects : More information on Actos Side Effects

After the initial shock of being given a new diagnosis of cancer, a flood of emotions follow with fear and anxiety being foremost. Questions fill your mind:

How serious is it?

Can 1 be cured?

Am I going to die?

Will I suffer?

What treatments are available?

Can 1 do anything to improve my odds?

What side effects will occur from the treatments?

Will I lose time from work?

Will my insurance cover the cost?

Will I be disfigured?

Will my spouse and family be supportive?

Do 1 have a good doctor?

Bladder cancer, or any serious potentially life threatening illness is generally alien to most individuals. Suddenly, lives are changed and a new reality must be dealt with. Becoming a “patient” or worse “a cancer patient” is not only threatening, but a dreaded proposition. Cancer patients are not happy with the loss of autonomy, the invasion of privacy, the discomfort inflicted upon them and the demands on their time and quality of life. As a patient, being thrust into this altered identity, it is essential to seek out the information you need. Having a fundamental base of knowledge is a must when facing the issues and treatment decisions which lie ahead. In the following pages, together we will explore bladder cancer, a disease which is totally foreign to most of us until the diagnosis is made. I have chosen to present the information in a question and answer format, written in a conversational tone, as if I were having an extended consultation with one of my patients. The questions are typical of what individuals have asked over the years. 1 have covered the key issues and decisions the individual with bladder cancer may face. The answers are to the point and cover the essentials required to make an informed decision for most individuals. For others, a more detailed resource may be required. For helpful sources of additional information see the Appendix.

Each individual’s situation is unique. Decisions on treatment may be modified based on the patient’s preferences and values and altered by other considerations such as age and coexisting conditions. By becoming an individual knowledgeable of bladder cancer, you will be prepared to fully partner with your physician for your best possible outcome. To your companions and family members, this book will serve to answer the many questions and doubts that may arise. Having your loved ones informed and supportive is a big plus for the individual facing this new challenge.

The book is written in a logical sequence starting with finding a qualified urologist to the basics on bladder cancer, its assessment and treatment. At the end of the book, you will find chapters on complementary medicine, advance care planning, and hospice care. The book can be read in sequence or each chapter can serve as a resource covering the basics of the topic. It is my hope this book will help clarify the many issues and options individuals must face with bladder cancer. For family members, significant others and concerned friends, this resource should help improve your understanding and thus your ability to assist your loved one.

 

Information from other sources on Actos Side Effects

Understanding bladder cancer is a tremendous first step that will assist you in your treatment. Having a qualified urologist administer the actual treatments and care for you is essential for the best possible outcome. In the following chapter, we will explore what you need to know to assure you have the right urologist.

BESIDES LEARNING ABOUT MY DISEASE, WHAT IS MY MOST IMPORTANT FIRST STEP?

Make sure you have an excellent urologist supervising your care. A urologist is a surgical specialist trained to care for conditions involving the male and female urinary tracts and the male reproductive system. The bladder is part of the urinary system, and a urologist is trained to care for problems involving it, including cancer.

IS IT IMPORTANT TO HAVE A BOARD CERTIFIED UROLOGIST?

A urologist board certified by The American Board of Urology has gone through an accredited urology training program (generally a four year program), following two years of internship and residency in surgery after four years of medical school. The urologist must be in practice after training and provide a detailed list of surgeries, including complications, over a twelve month period. The doctor will then take a two day oral and written test covering a wide spectrum of urology. If he passes, he is certified for a period of ten years. At the end of the ten year period, he must recertify to maintain his board status. Recertification entails a three month surgical and procedure log and a written test as well as reference letters from those in a position to judge the practicing urologist’s work. Any malpractice or judgments are also reviewed. Although being board certified does not guarantee you have an excellent urologist, it demonstrates that he has the fund of knowledge to practice urology competently. Even though board certification is voluntary, in today’s competitive environment more and more hospitals and insurance plans are requiring their specialists to be certified.

HOW CAN I TELL IF MY UROLOGIST IS BOARD CERTIFIED?

The urologist has worked hard to obtain board certification. The certificate from The American Board of Urology is often displayed openly in his office. If you do not see it, you can simply ask him or you can call 1-866-275-2267 or use this web site: www.certified doctor.org

SHOULD I TRY TO FIND A UROLOGIST WHO HAS BEEN IN PRACTICE FOR YEARS OR A NEWLY TRAINED ONE?

Surgery is a skill which can only be mastered with experience. The saying “practice makes perfect” definitely pertains to surgery. Although a urology training program offers the new physician years of training, his surgical skills will continue to improve with further experience. However, each individual physician has his own innate skills. Some more quickly learn and are simply better at the technical craft of surgery than others. For the most part, urologists finishing an accredited urology program have the training and skill set required to care for patients with bladder cancer.

Experience also counts. As a physician practices the art of medicine, his depth of knowledge and ability to treat grows. Ask your physician how long he has been treating patients with bladder cancer. If you require major surgery ask how many he has performed and if his complication rate matches what is expected.

Physicians by and large do improve as they practice, and all physicians are required to show that they are continuing to learn by partaking in continuing medical education, a requirement to remain licensed. Most physicians are compulsive in their medical practice and care deeply in the care they deliver. They continually strive to improve.

Some physicians may become “burned out” over the years as they continue to face the pressures of a busy medical practice. Similarly, towards the end of a surgeon’s career, technical skills may slip due to aging. New urologists are trained in the latest techniques and are familiar with recent medical literature, but may lack practical experience. In the end, recommendations from others and reputation may be your best guide to finding a qualified physician.

WHAT QUALITIES SHOULD MY UROLOGIST HAVE?

Ideally, you should have a competent, technically skilled surgeon who is also approachable and compassionate. You should be able to freely ask questions pertaining to your disease and treatment. Your physician should answer your questions forthrightly. Although some patients prefer a surgeon who will take over all aspects of care with no questions asked, most prefer in depth explanations, especially when alternatives exist and risks are involved.

Your urologist must be an individual who takes your concerns, priorities and values seriously. Your urologist should be a good communicator. It is his responsibility to keep you fully informed of your progress, make you aware immediately if things are not going well, and educate you fully in treatment alternatives. Your specific values should be incorporated into the decision process if alternatives are available. Even if your urologist makes a recommendation and you choose an alternative course (unless you are putting yourself in extreme jeopardy), he should honor your choice and continue his care of you. Becoming an educated patient will make your decision making process easier. Granted, your physician should provide you with the basics, however having time to review and digest the material will allow you to fully understand and accept your treatment regimen, providing you with peace of mind.

Beware of the physician who bombards you with statistics and studies and leaves the decision making to you. After all, you are not a physician and don’t have the practical hands on experience he does. Your physician should provide the facts and the statistics, guide you through the information, and make treatment recommendations based on your preferences.

You may find yourself emotionally distraught and overwhelmed. Having a physician on your side is invaluable. You should be able to trust your physician. Complete honesty on the part of your doctor in his care of you is a must. From the doctor’s point of view, trust is also a necessity. Physicians have an extremely difficult time dealing with individuals who do not trust them. Without trust, the physician patient relationship is extremely hindered.

Lastly, your urologist should be compassionate. Having cancer is tough enough, you shouldn’t have to deal with a rude or arrogant physician. Your urologist should be supportive at all times. He should treat you as an individual and not just as “another cancer patient.” People with bladder cancer will require long term follow up and care. Having a compassionate individual to work with will make a tremendous difference

HOW DO I FIND A GOOD BOARD CERTIFIED UROLOGIST?

A good starting point is your primary care physician. He will generally have a number of specialists to whom he generally refers his urology patients. If the primary care physician has been working with these urologists, he should have an appreciation of their skills and temperament. However, this does not mean he is referring you necessarily to the best available urologist in your area. His choices may be limited by insurance or hospital networks. An excellent source of information would be nurses who work in the operating room, recovery room or on the surgical floor where the urologist does his surgery. Asking friends or other individuals who have had experience with the urologist can also prove useful. After a little digging, you can often quickly learn what type of reputation the urologist has in the community. Generally, if an established urologist has a “good reputation” this is an indication that he has pleased many individuals with his care.

SHOULD I CHECK TO SEE HOW MANY TIMES MY UROLOGIST HAS BEEN SUED?

Given the litigious society we live in, most physicians can face at least one malpractice lawsuit during their careers. In urology, two of the most common causes of litigation would be a surgical mishap leading to a complication, or failure to diagnose cancer in a timely fashion.

Medicine is based on science, but also is an “art.” Individuals do not walk into their physicians offices with a diagnosis and treatment plan always readily apparent. Even the best intentioned, thorough physician will make mistakes. Most of these errors do not result in harm. On occasion they do, and a law suit may follow. If a physician develops a good working relationship with a patient, these bad outcomes more often than not are acknowledged and accepted without legal entanglement. Competent, busy physicians may be dealing with a higher mix of complicated patients, leading to a higher number of potential suits. Physicians who have poor “bed side manner” may find themselves dealing with more suits. If a physician has an inordinate number of suits, “red flags” should go up, as competency may be an issue.

For those individuals who wish to check out the malpractice history of their physician, you may request an inquiry from the National Practitioners Data Bank at: 1-800-767-6732 or check the web site: www.npdb-hipdb.com

Our use of the term or terms Actos Side Effects is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Side Effects visit our site often.

http://www.seedol.com

Posted in Cerebral Palsy News | Tagged , |

Actos and Bladder Cancer Bulletin

Actos and Bladder Cancer : BC is a disease of the environment and age . Populations are increasing in number, and they are growing old as well., . Since more people are living longer, more are at potential risk. Furthermore, the changing environments in developed and developing countries are causing more carcinogen concentration than can be associated to genesis of BC. Several carcinogens have been correlated to BC carcinogenesis.However, it has been proposed that other environmental factors could affect the incidence on urothelial tumors. In fact, as for many other cancers, molecular researchers try to establish genetic alterations linked to carcinogenesis that could justify genetic predisposition.

Cancer is a major public health problem. At the end of the twentieth century, more than 930,000 people died of cancer every year in 15 member countries of the European Union (EU) (Coleman et al. 2003). Using population projections, if the age-specific death rates remain constant, the absolute number of cancer deaths in 2015 will increase to 140,500 (Boyle and Ferlay 2005). BC is a worldwide health problem. In 2006 in Europe, there were an estimated 104,400 incident cases of BC

 

More information on Actos and Bladder Cancer

diagnosed (82,800 in men and 21,600 in women) that represent a 6.6% of the total cancers in men and 2.1% in women. The estimated ratio by gender was 3.8:1, respectively. In men BC was the fourth most common cancer. Bladder cancer repre­sents a 4.1% of total deaths for cancer in men and 1.8% of total deaths in women (Ferlay et al. 2007). In the EU overall (27 countries), BC mortality rates were stable up to early 1990s, and declined, thereafter, by 16% in men and 12% in women, to reach values of 6 and 1.3/100,000, respectively, in the early years of the present decade. The only countries without declining mortality are Croatia and Poland in both sexes, Romania in men, and Denmark in women. This documented and quanti­fied reduction in BC mortality seems related to decrease in tobacco smoking, while its relationship with other risk factors remains controversial (Ferlay et al. 2008).In the United States, it is estimated that about 1.4 million new cases of cancer was diagnosed in 2008. Cancers of the prostate and breast are the most frequently diagnosed cancers in men and women, respectively, followed by lung and colorec­tal cancers in both men and in women. The fourth most common among men is the urinary BC. The 5-year relative survival rate for BC is 81% among whites and 65% among African-Americans (AAs) (taking the normal life expectancy into consider­ation) with an absolute difference of 16%. The survival rates for BC combined with certain site-specific cancer have improved significantly since the 1970s—being 74% during 1975-1977, 78% during 1984-1986, and 81% during 1996-2003.

 

Information from other sources on Actos and Bladder Cancer

Contrary to this data, the prevalence of BC among Native Americans/Alaskan Natives (NA/AN) is generally considered to be low. Despite this low incidence, NA/AN men and women seem to be at relatively greater risk of dying from BC, once it has been diagnosed (Watson and Sidor 2008).Tobacco use is a major preventable cause of death, and especially involved in BC carcinogenesis. The year 2004 marks the anniversary of the release of the first Surgeon General’s report on Tobacco and Health, which initiated a decline in per capita cigarette consumption in the United States (Jemal et al. 2008).

In Egypt, where BC has always been related to bilharziasis, a significance decline of the relative frequency of BC was observed from 27.63% in the old series to 11.7% in the recent series. Bilharzias association dropped from 82.4% to 55.3% and there was a significant increase of transitional cell carcinoma from 16% to 65%, while squamous cell carcinoma was less frequent—from 76% to 28%. Intimately related to this, there was an increase in the median age of patients from 47 to 60 years. The decline in the frequency of BC is related to a decline in bilhar- zias egg positivity in the specimen, and this suggests a better control of the endemic disease in rural population. This trend of less association with bilharzias has changed the clinical and pathological characteristics of BC diagnosed, with signifi­cant predominance of transitional cell carcinoma and an increase in the age of patients, a pattern more similar to that in western series (Gouda et al. 2007).

The incidence and mortality rates associated with BC vary by country, ethnicity, gender, and age. For indeterminate causes, the AAs have only half the risk of white European Americans, but overall, the survival seems to be worse among the primer group. The higher incidence in European Americans is limited to superficial tumors, both groups having a similar risk of invasive tumor (Kirkali et al. 2005).

 

Our use of the term or terms Actos and Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos and Bladder Cancer visit our site often.

http://www.seedol.com

Posted in Cerebral Palsy News | Tagged , |